NAMPT-targeting PROTAC and nicotinic acid co-administration elicit safe and robust anti-tumor efficacy in NAPRT-deficient pan-cancers
Xiaotong Zhu, Ye Li, Haixia Liu, Yuetong Wang, Renhong Sun, Zhenzhou Jiang, Chun Hou, Xianyu Hou, Suming Huang, Huijuan Zhang, Haopeng Wang, Biao Jiang, Xiaobao Yang, Bin Xu, Gaofeng Fan
Topics & Concepts
Nicotinic agonistMedicineAdministration (probate law)PharmacologyCancer researchInternal medicineReceptorPolitical scienceLawProtein Degradation and InhibitorsPeptidase Inhibition and AnalysisPARP inhibition in cancer therapy